All In MedTech

FDA Clearance Tracker · P060037-S004

LPS-FLEX MOBILE

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Nov 6, 2008 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Nov 6, 2008

Approved

Time to decision

65 days

Received Sep 2, 2008. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P060037-S004
Device name
LPS-FLEX MOBILE
Applicant
Zimmer, Inc.
Applicant location
Warsaw, IN
Received
Sep 2, 2008
Decided
Nov 6, 2008
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol - OSB
Original approval
P060037

Device type

Device class
Class III

Every decision under product code NJL

FDA's approval statement

As written in FDA's record.

APPROVAL OF THE POST-APPROVAL STUDY PROTOCOL.

Source documents

Other decisions for Zimmer, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.